Caris Life Sciences,�Inc. (CAI)

Last Closing Price: 19.50 (2026-11-18)

Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

Caris Life Sciences,�Inc. (CAI) had Consolidated Net Income/Loss of $15.25M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$275.36M
$15.25M
$93.07M
$182.28M
$256.04M
$19.32M
$-2.44M
$16.87M
$16.87M
$15.25M
$15.25M
Consolidated Net Income/Loss
$15.25M
$15.25M
$19.32M
$26.23M
283.89M
295.14M
$0.05
$0.05
Balance Sheet Financials
$1.07B
$102.30M
$188.35M
$1.26B
$158.95M
$393.18M
$457.20M
$616.14M
$639.48M
$620.14M
$639.48M
286.72M
Cash Flow Statement Financials
$39.11M
$-150.00M
$-21.84M
$800.04M
$667.15M
$-132.89M
$56.59M
--
--
Fundamental Metrics & Ratios
6.71
--
--
0.38
0.61
66.20%
7.01%
7.01%
--
6.13%
5.54%
$-10.78M
--
--
--
0.22
0.67
2.07
43.58
2.38%
2.46%
1.21%
1.48%
$2.23
$-0.04
$0.13